Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide for GVHD Prevention in PBSCT
NCT03336632Phase 2Unknown
- Sponsor
- Sichuan University
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in graft-versus-host disease (GVHD), sponsored by Sichuan University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03336632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336632.